Stock Events

Stock Events

Supernus Pharmaceuticals (SUPN) Q3 2023 Earnings

8AugConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.23

0.08

0.39

0.7

Details

Expected EPS

-0.23

Actual EPS

-0.02

Surprise EPS

0.21

Surprise Percent

+91.3%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of -0.02 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.